BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Diagnosis
64 results:

  • 1. schwannomatosis: a Realm Reborn: year one.
    Planet M; Kalamarides M; Peyre M
    Curr Opin Oncol; 2023 Nov; 35(6):550-557. PubMed ID: 37820090
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Classification and Molecular diagnosis of Benign brain Tumors].
    Yoshimoto K
    No Shinkei Geka; 2023 Sep; 51(5):771-777. PubMed ID: 37743328
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review.
    Nobee A; Xu M; Seth A; Rong Y
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628996
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Extremely rare pediatric primary scrotum tumor: spermatic cord hemolymphangioma for a case report and literature review.
    Liu L; Xiao Y; Yue X; Wang Q
    World J Surg Oncol; 2023 Jul; 21(1):226. PubMed ID: 37495989
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Role of Advanced MR Imaging in diagnosis of Neurological Malignancies: Current Status and Future Perspective.
    Eraky AM; Beck RT; Treffy RW; Aaronson DM; Hedayat H
    J Integr Neurosci; 2023 May; 22(3):73. PubMed ID: 37258452
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nervous system (NS) Tumors in cancer Predisposition Syndromes.
    Patil P; Pencheva BB; Patil VM; Fangusaro J
    Neurotherapeutics; 2022 Oct; 19(6):1752-1771. PubMed ID: 36056180
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort.
    Foss-Skiftesvik J; Stoltze UK; van Overeem Hansen T; Ahlborn LB; Sørensen E; Ostrowski SR; Kullegaard SMA; Laspiur AO; Melchior LC; Scheie D; Kristensen BW; Skjøth-Rasmussen J; Schmiegelow K; Wadt K; Mathiasen R
    Acta Neuropathol Commun; 2022 Aug; 10(1):123. PubMed ID: 36008825
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. YAP1-MAML2 fusion in a pediatric nf2-wildtype intraparenchymal brainstem schwannoma.
    Karajannis MA; Li BK; Souweidane MM; Liechty B; Yao J; Benhamida JK; Bale TA; Rosenblum MK
    Acta Neuropathol Commun; 2022 Aug; 10(1):117. PubMed ID: 35986430
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know.
    Wang MX; Dillman JR; Guccione J; Habiba A; Maher M; Kamel S; Panse PM; Jensen CT; Elsayes KM
    Radiographics; 2022; 42(4):1123-1144. PubMed ID: 35749292
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.
    Evans DG; Mostaccioli S; Pang D; Fadzil O Connor M; Pittara M; Champollion N; Wolkenstein P; Thomas N; Ferner RE; Kalamarides M; Peyre M; Papi L; Legius E; Becerra JL; King A; Duff C; Stivaros S; Blanco I
    Eur J Hum Genet; 2022 Jul; 30(7):812-817. PubMed ID: 35361920
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multiple Meningiomas as a Criterion for the diagnosis of Neurofibromatosis Type 2 and Other Tumor Predisposition Syndromes.
    Hannan CJ; Hammerbeck-Ward C; Pathmanaban ON; Smith MJ; Rutherford SA; Lloyd SK; Mackenzie Freeman SR; Wallace AJ; King AT; Richard Evans DG
    Neurosurgery; 2022 Jun; 90(6):793-799. PubMed ID: 35343466
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Intracranial metastasis from a malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1: A case study and literature review.
    Griffin S; Witt MC; El Tecle N; Prim M; Hockman J; Schwetye KE; Pierson MJ
    Clin Neurol Neurosurg; 2021 Apr; 203():106540. PubMed ID: 33607580
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Neurofibromatosis Type 2 (nf2) and the Implications for Vestibular schwannoma and Meningioma Pathogenesis.
    Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution.
    Forde C; King AT; Rutherford SA; Hammerbeck-Ward C; Lloyd SK; Freeman SR; Pathmanaban ON; Stapleton E; Thomas OM; Laitt RD; Stivaros S; Kilday JP; Vassallo G; McBain C; Kerrigan S; Smith MJ; McCabe MG; Harkness EF; Evans DG
    Neuro Oncol; 2021 Jul; 23(7):1113-1124. PubMed ID: 33336705
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical-Pathological, Immunohistochemical, and Genetic Characterization of a Series of Posterior Pituitary Tumors.
    Barresi V; Simbolo M; Gessi M; Rossi S; Caffo M; Eccher A; Angileri FF; Cannavò S; Brunelli M; Scarpa A
    J Neuropathol Exp Neurol; 2021 Jan; 80(1):45-51. PubMed ID: 33212494
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
    Abi Jaoude S; Peyre M; Degos V; Goutagny S; Parfait B; Kalamarides M
    J Neurosurg; 2020 May; 134(5):1377-1385. PubMed ID: 32442973
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis.
    Farschtschi SC; Kluwe L; Schön G; Friedrich RE; Matschke J; Glatzel M; Weis J; Hagel C; Mautner VF
    Brain Pathol; 2020 Mar; 30(2):386-391. PubMed ID: 31424590
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cell-free circulating tumor DNA in patients with high-grade glioma as diagnostic biomarker - A guide to future directive.
    Ahmed KI; Govardhan HB; Roy M; Naveen T; Siddanna P; Sridhar P; Suma MN; Nelson N
    Indian J Cancer; 2019; 56(1):65-69. PubMed ID: 30950448
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Intraoperative assessment of isocitrate dehydrogenase mutation status in human gliomas using desorption electrospray ionization-mass spectrometry.
    Alfaro CM; Pirro V; Keating MF; Hattab EM; Cooks RG; Cohen-Gadol AA
    J Neurosurg; 2019 Jan; 132(1):180-187. PubMed ID: 30611146
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.